Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment ...

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...

Ulcerative colitis in children is often characterized by extensive colitis with a cumulative rate of colectomy up to 40% at 10 years. Scheduled combination therapy with anti-TNF (and pretreatment ...

The primary endpoint was clinical remission at week 12, with secondary endpoints of clinical response and endoscopic ...

Eli Lilly announced that mirikizumab achieved long-term remission in Phase 3 IBD studies, showing promise for ulcerative ...

Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

ALTB-268 demonstrated its anti-inflammatory effect in an acute colitis hPSGL-1 mouse model.The data confirmed that ALTB-268 acts as an immune ...

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Untreated ulcerative colitis can lead to severe dehydration and malnutrition as well as other conditions, like arthritis and osteoporosis. It’s important to speak with a doctor to learn how ...

Results provide a mechanistic explanation of why early loss of p53 signaling is frequently observed in UC-associated ...

Prademagene zamikeracel (pz-cel) could be a new treatment for rare genetic disease recessive dystrophic epidermolysis bullosa (RDEB).

or other biologics,” she continued. “These are key goals in the treatment of ulcerative colitis to minimize disease-related disability.” 87% of those with Crohn’s have clinical remission ...